The Hippo (Hpo) pathway controls tissue growth and organ size by regulating the activity of transcriptional co-activator Yorkie (Yki), which associates with transcription factor Scalloped (Sd) in the nucleus to promote downstream target gene expression. Here we identify a novel protein Sd-Binding-Protein (SdBP)/Tgi, which directly competes with Yki for binding to Sd through its TDU domains and inhibits the Sd-Yki transcriptional activity. We also find that SdBP retains Yki in the nucleus through the association with Yki WW domains via its PPXY motifs. Collectively, we identify SdBP as a novel component of the Hpo pathway, negatively regulating the transcriptional activity of SdYki to restrict tissue growth.
Introduction
Among developmental processes, organ size control is one of the critical steps. Failure of appropriate organ size control results in diseases including tumorigenesis. In the past decade, the Hippo (Hpo) signaling pathway was identified as one of the important signaling pathways that regulate organ growth [1] [2] [3] [4] . This pathway was first identified in Drosophila and is highly conserved in mammals. The serine/threonine Ste20-like kinase Hpo and the nuclear Dbf-2-related (NDR) family kinase Warts (Wts) associate with two scaffold proteins Salvador (Sav) and Mob as tumor suppressor (Mats) to induce a series of phosphorylation events, which is considered to be the core of the Hpo pathway [5] [6] [7] [8] [9] [10] [11] [12] . This kinase cascade results in the inactivation and cytoplasmic retention of transcriptional co-activator Yorkie (Yki, YAP in mammals) [13, 14] . In the absence of Hpo signaling, Yki translocates into the nucleus and binds to the transcription factors such as Scalloped (Sd, TEAD/TEF family of proteins in mammals) [15] [16] [17] to promote proliferation and inhibit apoptosis by regulating the expression of Hpo pathway target genes including diap1, cyclin E and bantam [18, 19] .
Sd is the only TEAD/TEF protein family member in Drosophila [20] . Unlike Drosophila, mammals contain four closely related TEAD/TEF family members, TEAD1-TEAD4. They are expressed widely during development and regulate the development of various tissues, including heart, skeletal muscles, neural crest, notochord and trophoectoderm [21] [22] [23] [24] [25] . The function of Sd-Yki complex has been intensively studied. In mammals, the structure and function of TEAD-YAP were well characterized [26] [27] [28] . Recent studies revealed that mammalian TEAD proteins are involved in the regulation of cell proliferation by cooperating with YAP under the control of Hpo signaling [29] [30] [31] [32] . Interestingly, both genetic studies in Drosophila and pharmacological studies in transgenic mice revealed that loss of sd or inhibition of TEAD has minimal impact on normal tissue homeostasis and physiology, suggesting that Sd/TEAD is required for Yki/YAP-mediated tissue overgrowth but is largely dispensable for normal tissue homeostasis [15, 16, 33] .
As YAP has been implicated in organ overgrowth and various human cancers [4, 29, 34] , this interesting prop-erty of TEAD may provide us a good opportunity to develop pharmacologically viable strategy against the YAP oncoprotein. However, so far, hardly any component(s) that directly inhibit Sd-Yki/TEAD-YAP complex activity has been identified. In this study, we report the discovery of a novel Sd binding protein, Sd-Binding-Protein (SdBP). We find that it directly interacts with Sd via its TDU domains and with Yki through its PPXY motifs. We also reveal that it serves as an inhibitor of Sd-Yki transcriptional complex. Moreover, we provide evidence that SdBP and Yki compete with each other for Sd binding to regulate the transcriptional activity of Sd-Yki complex, thereby keeping the homeostasis of tissue growth.
Results

Identification of SdBP as an Sd-binding partner
To gain understanding of the regulatory mechanism of Sd-Yki complex, we performed yeast two-hybrid (Y2H) analysis using Sd C-terminal fragment (208-440 aa) as a bait to screen the Drosophila embryo cDNA library. We found that a protein (named as Sd-Binding-Protein, SdBP, encoded by CG10741) associated with Sd in Y2H assay (Supplementary information, Figure S1A ).
To verify the interaction between SdBP and Sd in vitro, we performed co-immunoprecipitation experiment using full-length Sd and SdBP in Schneider 2 (S2) cells. Strong binding between Sd and SdBP in vitro was observed ( Figure 1A ). Subsequent GST pull-down assay confirmed a direct interaction between Sd and SdBP (Supplementary information, Figure S1B ). In addition, we found that SdBP is a nuclear protein and co-localizes with Sd in the nucleus when expressed by Gal4 driver MS1096 (Supplementary information, Figure S1C -S1E'''). Taken together, these results identify SdBP as a novel binding partner of Sd.
There are two annotated transcripts of SdBP in FlyBase (http://flybase.org/reports/FBgn0036373.html). Expression of either isoforms of SdBP, SdBP-RA and SdBP-RB, under the control of MS1096 resulted in growth inhibition (Supplementary information, Figure  S1F -S1F'''). No distinguishable difference between SdBP-RA and SdBP-RB in function and subcellular localization was observed (Supplementary information, Figure S1F -S1G'); we chose SdBP-RB for further study.
SdBP overexpression antagonizes Sd-Yki-induced tissue overgrowth
To probe the function of SdBP, we first examined the expression pattern of SdBP in different tissues including eye discs and wing discs by immunostaining and in situ assay. An antibody of SdBP was generated and validated using immunostaining by expressing SdBP RNAi transgene under the control of hh-Gal4, which drives gene expression in the posterior compartment (P-compartment) of Drosophila imaginal discs (Supplementary information, Figure S2A -S2A"). We observed that SdBP is ubiquitously expressed in eye discs and wing discs without a specific pattern (Supplementary information, Figure  S2B -S2C' and S2D-S2E'). It is known that Sd is a transcription factor, and forms a transcriptional complex with Yki to control tissue growth in the Hpo pathway [15] [16] [17] . As SdBP binds to and co-localizes with Sd in vitro and in vivo ( Figure 1A and Supplementary information, Figure S1A -S1E'''), we performed analyses to investigate whether SdBP plays a role in regulating SdYki transcriptional activity. SdBP was subjected to a dual luciferase assay that can reflect Sd-Yki transcriptional activity. In S2 cells, coexpression of Yki and Sd activated the luciferase (Luc) reporter gene, 3xSd2-Luc [15] ( Figure  1B ). Coexpressing SdBP sharply decreased the activity of Sd-Yki complex ( Figure 1B ), suggesting that SdBP influenced Sd-Yki activity. In addition, this inhibition is specific as only mild change was observed when we tested SdBP using Wnt and Hh reporters (Supplementary information, Figure S2F-S2G) .
To probe the function of SdBP on Sd-Yki activity in vivo, we overexpressed SdBP under the control of GMRGal4 in Drosophila compound eyes. Overexpression of UAS-SdBP posterior to morphogenetic furrow using the GMR-Gal4 driver resulted in mild growth defects in eyes, compared with controls (compare Figure 1D with 1C). Yki overexpression-induced overgrowth phenotype was completely suppressed by coexpression of SdBP (compare Figure 1F with 1E) . Furthermore, the GMRYki-induced increase in BrdU (a DNA replication maker) incorporation was diminished by coexpression of SdBP ( Figure 1C '-1F'). These results suggest that SdBP suppresses growth through antagonizing Sd-Yki activity.
Gain of function of SdBP inhibits tissue growth through regulating the Hpo pathway
To verify whether SdBP overexpression induced growth defects via regulating the Hpo pathway, we expressed SdBP in flip-out clones to examine the changes in the expression of the Hpo pathway target genes. We observed a downregulation of DIAP1 and Ex proteins in SdBP-overexpressed regions (Figure 2A-2B' ). Similar changes in diap1-lacZ (an enhancer trap for diap1 that reflects its transcriptional level) and ex-lacZ signals (an enhancer trap for expanded in response to Hpo signaling [35] ) were observed (Supplementary information, Figure  S3A -S3B"). The microRNA bantam is a Hpo pathway target that promotes cell growth [18, 19] . We found that Figure S3C -S3C"). Briefly, SdBP inhibits tissue growth by restricting the expression of the Hpo pathway target genes.
To further dissect the function of SdBP in the Hpo pathway, we used mosaic analysis with a repressible cell marker (MARCM) system to express SdBP in hpo or sav mutant clones. We found that eye discs carrying hpo BF33 or sav SH13 mutant clones exhibited overgrowth and elevated DIAP1 levels, resulting in enlarged and folded adult eyes ( Figure 2C -2C''' and 2E-2E'''). Overexpressing SdBP in these mutant clones antagonized the overgrowth of mutant clones and the increase of DIAP1 in clone regions, resulting in nearly normal adult eyes (compare Figure 2D -2D''' and 2F-2F''' with 2C-2C''' and 2E-2E'''). These pieces of evidence suggest that SdBP represses overgrowth phenotypes induced by loss of function of upstream Hpo signaling members.
TDU domains and PPXY motifs mediate the interactions of SdBP with Sd and Yki, respectively
We have demonstrated that SdBP induces growth suppression through antagonizing the activity of Sd-Yki complex. We next sought to investigate the mechanisms by which SdBP regulates Sd-Yki activity. According to its primary sequence ( Figure 3A ), we generated several SdBP variants that contained mutations in its two TDU domains. TDU domain is highly conserved and has been shown to interact with TEAD/TEF family members [36] ; therefore, we speculated that these two TDU domains might mediate the binding between SdBP and Sd. To verify this hypothesis, we performed co-immunoprecipitation and GST pull-down experiments using SdBP variants that carry mutations either in both TDU domains (TDU12) or in one of the TDU domains (TDU1 and TDU2) ( Figure  3A -3C and Supplementary information, Figure S4A ). The association between SdBP and Sd was completely abolished when both TDU domains were mutated, while the binding was still retained when single TDU domain was mutated ( Figure 3C and Supplementary information, Figure S4A ). These results suggest that both the TDU domains of SdBP are involved in the association of SdBP with Sd. It was also reported that the Hpo pathway components utilize the WW domain and PPXY motif for proteinprotein interactions in a common way [37, 38] . Noticing that SdBP contains three PPXY motifs ( Figure 3A) , we speculated that a binding between SdBP and Yki through PPXY motifs and WW domains might exist. To verify this hypothesis, we performed co-immunoprecipitation and Y2H assays. An interaction between SdBP and Yki was detected ( Figure 3D and Supplementary information, Figure S4B ). To confirm whether the binding is mediated by PPXY motifs and WW domains, SdBP variants carrying mutations either in all PPXY motifs (PPXY123) or in one of the PPXY motifs (PPXY1, PPXY2 and PPXY3) were used in co-immunoprecipitation ( Figure 3E ) and GST pull-down assays (Supplementary information, Figure S4C ). We found that all three PPXY motifs are involved in mediating the binding between SdBP and Yki as only the triple mutation completely abolished the binding between SdBP and Yki ( Figure 3E and Supplementary information, Figure S4C ). In addition, deletion of both C-terminal WW domains of Yki abolished SdBPYki interaction (Supplementary information, Figure  S4D ). In brief, SdBP binds to Yki WW domains through its PPXY motifs.
To further explore the binding specificity between SdBP and Sd-Yki complex, we applied co-immunoprecipitation and GST pull-down assays, and found that TDU12 did not affect SdBP-Yki association, and PPXY123 did not affect SdBP-Sd interaction ( Figure 3F and 3G and Supplementary information, Figure S4E ), implying that SdBP-Sd association and SdBP-Yki association are independent of each other. Moreover, the SdBP variant carrying mutations in both TDU domains and all PPXY motifs (TDU12+PPXY123) did not bind to either Sd or Yki ( Figure 3F and 3G and Supplementary information, Figure S4E ). In addition, no direct interactions between SdBP and other known Hpo pathway components, such as Mer, Wts or Mats, were detected (Supplementary information, Figure S4F ), suggesting that the function of SdBP in vivo in growth control is through its association with Sd-Yki complex.
TDU domains and PPXY motifs are critical for the function of SdBP in growth inhibition
We next focused on exploring whether the function of SdBP in growth inhibition was dependent on TDU domains and PPXY motifs. Using a dual luciferase assay, we found that both SdBP variants, TDU12 and PPXY123, weakened the strength of the function of SdBP on Sd-Yki activity, whereas TDU12+PPXY123 no longer suppressed Sd-Yki activity ( Figure 4A ), implying that both TDU domains and PPXY motifs played important roles in regulating Sd-Yki activity in vitro. To further confirm these findings, we generated transgenic flies carrying different combination of mutations of these domains. Similar to what have been observed in luciferase assay ( Figure 4A ), when coexpressing SdBP variants with Yki under the control of GMR driver, only TDU12+PPXY123 was totally incapable of inhibiting the overgrowth phenotype induced by GMR-Yki (compare Figure 4G with 4B-4F). TDU12+PPXY123 might also have a dominant-negative function as its expression drove the eyes even larger and more folded than the GMR-Yki control (compare Figure 4G 
SdBP forms a complex with Sd and Yki in the nucleus
We have demonstrated that SdBP binds to Sd and Yki independently and suppresses their activity, however, the detailed mechanism by which SdBP suppresses Sd-Yki activity is unclear. To figure out the underlying mechanism, we performed a two-step immunoprecipitation experiment. We found that SdBP, Sd and Yki associate with each other and form a ternary complex ( Figure  5A ). To confirm this, we examined the localization of these proteins in Drosophila wing discs by overexpression. To clearly visualize the localization of these proteins, we generated GFP-fused SdBP Figure 5D and 5D" with 5B-5B'). This even distribution of Yki in cells was also observed when Sd and Yki were coexpressed ( Figure 5C -5C'). When SdBP, Sd and Yki were coexpressed, the majority of Yki anchored in the nucleus ( Figure 5E -5E'''), implying that Yki is retained in the nucleus upon SdBP coexpression. Moreover, expressing SdBP inhibited Sd- 
B), GMR-Gal4/UAS-Yki (C), GMR-Gal4/UAS-(Yki+SdBP) (D), GMR-Gal4/UAS-(Yki+TDU12) (E), GMR-Gal4/UAS-(Yki+PPXY123) (F), and GMR-Gal4/UAS-(Yki+(TDU12+PPXY123) ) (G). (H-L) Adult wings of wild-type (H), or wings expressing UAS-SdBP (I), UAS-TDU12 (J), UAS-PPXY123 (K), and UAS-(TDU12+PPXY123) (L) under the control of MS1096. (M) Quantification of relative wing sizes (fold change) of samples indicated in H-L. (N-R') Control wing discs (N) and wing discs expressing UAS-SdBP (O-O'), UAS-TDU12 (P-P'), UAS-PPXY123 (Q-Q') and UAS-(TDU12+PPXY123) (R-R') by hhGal4.
SdBP (green) and DIAP1 (blue) were stained. Arrows indicated the P-compartment. 
GFP (E-E'''). Discs were stained with α-Myc (red), α-HA (magenta) antibodies and DAPI (blue). (F-G') Adult eyes expressing GMR-Gal4/UAS-(Sd+Yki) (F) and GMR-Gal4/UAS-(Sd+Yki+SdBP) (G). BrdU staining of eye discs expressing UAS-(Sd+Yki) (F') and UAS-(Sd+Yki+SdBP) (G') under the control of GMR-Gal4.
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npg Yki overexpression-induced overgrowth of adult eyes as well as BrdU increase ( Figure 5F -5G'), further indicating that SdBP suppresses the activity of Sd-Yki complex. In summary, SdBP retains Yki in the nucleus and simultaneously forms a complex with Sd, while Sd-Yki activity is inhibited by the presence of SdBP.
SdBP and Yki compete with each other for Sd to control tissue growth
We showed that overexpressed SdBP forms a complex with Sd-Yki in the nucleus and inhibited their activity. To further explore the role of SdBP in the Hpo pathway, we generated a null mutation by "ends-out" gene targeting in which most of the SdBP coding sequence was replaced by white gene [39] . Three independent null alleles, sdbp A , sdbp B and sdbp 36 , were isolated. Homozygotes of these alleles exhibit lethal phenotypes before the third instar larval stage. We used sdbp B allele to carry out further analyses (Supplementary information, Figure S7A -S7A"). Interestingly, no discernible changes of clonal growth and the protein levels of DIAP1 and Ex were observed in the sdbp B mutant clones in eye and wing imaginal discs ( Figure 6A -6A''' and Supplementary information, Figure S7B -S7B"). Similar to the phenotypes induced by the loss of sd in eye discs [15] , loss of sdbp did not affect the expression of the Hpo pathway downstream markers. In addition, loss of sdbp did not affect the protein levels and subcellular localization of Sd or Yki (Supplementary information, Figure S7C -S7D"). It has been shown previously that Sd is absolutely required for tissue overgrowth induced by excessive Yki activity and loss of Sd suppresses the overgrowth phenotype as well as ectopic Hpo target gene expression caused by Yki overexpression [15] . Nevertheless, compared with Yki overexpression control ( Figure 6B -6B'''), loss of sdbp exhibited neither decrease nor increase in clone size or ectopic diap1 expression induced by Yki overexpression in sdbp B MARCM clones ( Figure 6C -6C'''). Altogether, although neither sd nor sdbp is essential for normal eye development, the difference between them is that loss of sdbp does not influence the phenotypes induced by excessive Yki activity in eye imaginal discs.
In order to explain how the transcriptional activity of nuclear Yki is inhibited by SdBP coexpression, we performed dosage-dependent GST pull-down and co-immunoprecipitation assays. We found that, upon SdBP binding, wild-type SdBP did not affect the stability of Sd-Yki complex while its variant carrying PPXA mutation in all PPXY motifs (SdBP-PPXY123) competed with Yki for Sd ( Figure 6D and Supplementary information, Figure  S7E ). Conversely, we found that, Yki also competed with SdBP-PPXY123 ( Figure 6E and Supplementary information, Figure S7F ). These findings suggest that SdBP and Yki compete with each other for Sd binding in a concentration-dependent manner. However, only SdBP PPXY variant shows the dual competition ( Figure 6D-6E) . Instead, wild-type SdBP forms a complex with SdYki ( Figure 5A ). To further investigate this intriguing finding, we employed the fluorescence resonance energy transfer (FRET) assay to detect the influence exerted by SdBP on the protein-protein interaction between Sd and Yki. In FRET assay, the transfer of energy between cyan fluorescent protein (CFP) and yellow fluorescent protein (YFP) was measured. Fusion proteins with CFP fused to the N-terminus of Sd (CFP N -Sd) and YFP fused to the Nterminus of Yki (YFP N -Yki) were generated to examine whether the interaction between Sd and Yki could be affected by coexpressing SdBP in S2 cells. We observed that the FRET efficiency was decreased between CFP NSd and YFP N -Yki when SdBP was cotransfected ( Figure  6F ), suggesting that SdBP competes with Yki for Sd while simultaneously interacts with Yki via its PPXY motifs, resulting in the nuclear retention and dysfunction of Yki protein.
Discussion
The evolutionarily conserved Hpo signaling pathway has emerged as a pivotal pathway that plays a critical role in controlling tissue growth and organ size. The Sd-Yki (D) GST pull-down assay showed that wild-type SdBP did not affect the stability of SdYki complex while SdBP-PPXY123 competed with Yki for Sd. His-YkiC plus dosage increased wild-type SdBP or SdBP-PPXY123 was pulled down by GST-Sd, followed by western blot using the indicated antibodies. (E) GST pull-down assay showed that Yki also competed with SdBP-PPXY123 for Sd. Wild-type SdBP or SdBP-PPXY123 plus dosage increased HisYkiC were pulled down by GST-Sd, followed by western blot using the indicated antibodies. In this study, using genetic and biochemical analyses, we identified SdBP as a novel negative regulator of Sd-Yki complex and found that it suppresses cell growth. Our data show that SdBP simultaneously binds to Sd through TDU domains and Yki via PPXY motifs ( Figure 6 ). This association disrupts the direct interaction between Yki and Sd ( Figure 6F ), but results in a transcriptional inactivated ternary complex to precisely regulate the direction and intensity of Hpo signaling. We reason that SdBP competes with Yki for the binding to Sd, as a result, within the ternary Sd-SdBP-Yki complex, Yki binds to PPXY motifs of SdBP, leading to an inhibition of Yki activity. Indeed, ectopic SdBP expression clearly suppresses the activity of Yki despite its nuclear location ( Figure 5 ). We further uncover a mutual competition of SdBP and Yki in binding to Sd. SdBP and Yki compete for Sd with a balance in normal physiological condition, resulting in neither growth defects nor growth advances. The Yin-Yang harmonization might promote the relative equilibrium of Hpo signaling in growth control. In the normal physiological condition, SdBP forms a repressor complex with Sd through unknown mechanisms in the nucleus, while the majority of Yki proteins are restricted in the cytoplasm by the upstream Hpo signaling ( Figure  6G ). Of note, Yki should be more competitive compared with SdBP, suggested by the structure information of the YAP-TEAD complex and the Vgll1-TEAD complex [40] . Similar to the YAP/Vgll1 and TEAD complexes, Yki and SdBP may form interfaces 1 and 2 in the TEADinteracting regions and may compete for binding to the same surface on TEAD, yet, Yki may contain an extra interface 3 compared with SdBP. Therefore, a low concentration of nuclear Yki protein may be sufficient to antagonize SdBP for normal tissue growth. However, a small amount of nuclear Yki is essential for tissue homoeostasis under normal conditions as suggested by previous finding that yki mutant clones grew poorly [41] . This might be due to the fact that in the absence of Yki, the fine balance between Yki and SdBP is disturbed, thus SdBP readily binds to Sd for efficient repression due to its nuclear localization. On the other hand, in the absence of SdBP, the existing small amount of nuclear Yki proteins can hardly induce the excessive expression of the Hpo pathway target genes, while the majority of Yki proteins are restricted in the cytoplasm by Hpo signaling; therefore, no obvious growth advances were observed in sdbp mutant clones ( Figure 6A -6A''' and Supplementary information, Figure S7B ). In the absence of Hpo signaling or in the case of Yki overexpression, abundant Yki proteins translocate into the nucleus and dominate for Sd regardless of whether SdBP existed ( Figure 6G ), resulting in elevated expression of Hpo pathway target genes ( Figures 2C-2C ''', 2E-2E''' and 6B-6C''').
It has been shown previously that Sd acts in conjunction with Vestigial (Vg) and other transcription factors to promote wing development by directly regulating the expression of wing patterning genes [42, 43] . In addition to its expression in wing discs as Vg, Sd is also expressed in other tissues and plays a broader role than Vg during development. In conjunction with Yki, Sd may be required for the basal expression of genes that can be suppressed by Hpo signaling in other tissues. Importantly, Sd is required for tissue overgrowth by regulating the expression of genes involved in cell proliferation, cell growth, and apoptosis when Yki is hyper-activated [15] [16] [17] .
In mammals, four genes encode TDU domain-containing proteins. Vestigial like 1, 2 and 3 have only one TDU domain; vestigial like 4 (Vgll4/Vgl4) has two TDU domains. It has been reported that Vgll4 is the mammalian homolog of SdBP and binds to TEAD [44] . Interestingly, we identified that Vgll4 was frequently downregulated in human lung cancer specimens as a novel tumor suppressor through the direct competition with YAP for binding to TEAD4 (Zhang WJ et al., in submission) . In contrast to SdBP, Vgll4 has 2 TDU domains but no PPXY motifs. Although Vgll4 cannot form a complex with YAP-TEADs in a way similar to SdBP, the competition of SdBP for Yki activity may be functionally and evolutionally conserved from Drosophila to mammals. This is consistent with the independent study by Koontz et al. showing that SdBP (named as Tondu-domain containing Growth Inhibitor (Tgi) in their study) and Vgll4 are conserved to work as negative regulators of Yki/YAP through a direct competition for Sd/TEAD2 binding [45] .
Introduction of SdBP to Sd-Yki complex may bring us new ideas for the regulation of downstream Hpo pathway. As YAP is a known proto-oncogene in many cancers, the identification of SdBP/Vgll4 may provide us a promising therapeutic strategy for inhibiting YAP tumorigenic function in the future.
Materials and Methods
Y2H screens
Sd C-terminus (208-440 aa) fragment was used as baits to screen a Drosophila embryo cDNA library using the Matchmaker Gold Yeast Two-Hybrid system according to manufacturer's instructions (Clontech). SdBP-Sd interacting clones were selected for their ability to activate four independent reporter genes (AUR1-C, ADE2, HIS3 and MEL1). The interaction between SdBP and Sd was further confirmed by co-immunoprecipitation. The interaction between SdBP and Yki was confirmed by Y2H assays. pGBKT7-Sd-C/pACT2-Yki and pGBKT7-Yki/pACT2-Sd were used as a positive control mating. pGBKT7-Sd-C/pACT2 and pGBKT7-Yki/pACT2 were used as a negative control mating.
Cloning of expression constructs
SdBP cDNA or its variants were amplified by PCR and introduced into the pUAST-Flag or pUAST-3× Flag vector by using the restriction enzymes BglII and XhoI. pUAST-Myc-Yki and pUAST-HA-Sd constructs were previously described [15] . All PCR-amplified products were sequence-verified.
Drosophila genetics
All crosses and staging were done at 25 °C unless specifically indicated. UAS-SdBP or its variants flies were generated by cloning SdBP or its variants after PCR amplification into the pUAST, and injected into yw flies. For flip-out ectopic expression clones, UAS-transgenes with Flag-SdBP were crossed to AG4 flies. All lines gave qualitatively identical phenotypes. SdBP RNAi stock (no. 34394) was provided by Bloomington Drosophila Stock Center (BDSC). HA-Sd;Myc-Yki recombinants were generated from the described stocks. Ectopic expression was induced in eyes using GMR-Gal4, in wings using MS1096, and in posterior cells using hhGal4. Mutant clones were generated using the MARCM system [46] . The genotypes for generated clones are as follows: ( Figure S7A '', S7B-S7B'', S7C-S7C'', S7D-S7D'') hs-FLP; ;FRT80B sdbp B /FRT80B GFP. For generated SdBP mutant, SdBP knockout construct was generated according to the ends-out gene targeting strategy [39] . The targeting construct is expected to replace most of the coding sequence of sdbp with white gene in pW25 vector. Two pairs of oligos: 1) 5′-ATTT-GCGGCCGCCAGTTGCAGTTGCACTCAGGTTCGT-3′ and 5′-ATTTGCGGCCGCGCTGTGGCTTTGCGGTTGATTTGGG-3′ and 2) 5′-TTGGCGCGCCCCAATTCCCAACAGAACTCAACA-CA-3′ and 5′-TTGGCGCGCCCAGCATTATTGTTGCTCGAC-GTGTT-3′ were used to amplify DNA fragments of about 4.8 kb from Drosophila genomic DNA. These two fragments were cloned into the NotI and AscI sites of pW25, respectively. Flies carrying the targeting construct on the second chromosome were crossed to y [1] w[*]; P{70FLP}23 P{70I-SceI}4A/TM6 (BDSC), and the following steps were performed as described previously [39] .
Cell culture, transfection, co-immunoprecipitation, western blot, real-time PCR and luciferase reporter assays
Drosophila S2 cells were maintained in Schneider's medium supplemented with 10% fetal bovine serum at 25 °C. Cells were transiently transfected using Lipofectamine (Invitrogen) according to the manufacturer's instructions. After 48 h of expression, cells were lysed in 1% Trition X-100 lysis buffer (50 mM Tris, pH 7.5, 150 mM NaCl, 1% Triton X-100 and 1 mM EGTA) supplemented with Protease Inhibitor Cocktail (Roche). For co-immunoprecipitation, cells were lysed in NP-40 buffer (50 mM Tris-Cl, pH 8.0, 0.1 M NaCl, 1% NP-40, 10% Glycerol, 1.5 mM EDTA, 10 mM Sodium fluoride, 1 mM Sodium vanadate, Protease Inhibitor Cocktail) for 30 min at 4 °C. Lysates were incubated with the indicated antibodies for 2 h or overnight at 4 °C. Samples were combined with 25 µl Protein A/G PLUS agarose (Santa cruz) for 1 h at 4 °C. Beads were washed three times with NP-40 buffer, followed by western blot assay. For two-Step IP, Flag M2 affinity gel (Sigma) was used in the first-step IP, beads from the first IP were eluted with 3× Flag peptide (Sigma) and then mixed with Myc antibody in the second-step IP. Western blot was performed according to standard protocols. Protein gels were run and blotted using the Mini-PROTEAN Tetra Electrophoresis system (Biorad). Purified and associated proteins were detected by western blot analysis using chemiluminescence (Western Lightning Plus-ECL, PerkinElmer). Western blots were probed with antibodies against mouse α-HA (Sigma), mouse α-Flag (Sigma), mouse α-Myc (Sigma), mouse α-His (Sigma), and mouse α-HRP (Santa cruz) using dilutions of 1:5 000 for all antibodies. Rabbit α-SdBP antibody was generated using SdBP full-length protein, and used with dilution of 1:1 000 in western blot. Real-time PCR was performed using standard protocols. Luciferase reporter gene assay was performed using protocols as described previously [15] .
GST pull-down assay
Glutathione agarose beads (GE) were used to purify the indicated proteins. These GST fusion beads were incubated with either S2 cell lysates or purified proteins in GST pull-down lysis buffer (20 mM Tris-Cl, pH 8.0, 200 mM NaCl, 1 mM EDTA, 0.5% NP-40 and 1% PMSF) at 4 °C for 1 h, followed by washing three times with GST pull-down lysis buffer and western blot analysis.
Immunostaining
Wing and eye imaginal discs from third-instar larvae were dissected, fixed for 25 min in 4% formaldehyde and washed three times in PBS supplemented with 0.1% Triton X-100 (PBS-T). Discs were incubated in the primary antibody diluted in PBS-T for 2 h at room temperature, followed by three washes with PBS-T and incubation with a secondary antibody in PBS-T for 2 h at room temperature. After three further washes, discs were mounted in PBS/glycerol medium with DAPI. Dilutions for the antibodies against mouse α-Myc, mouse α-HA, mouse α-Flag, mouse α-CD2 (Invitrogen) and rabbit α-SdBP were 1:200. Antibodies: rabbit α-Sd (1:50, produced by immunizing rabbits with the peptide of Sd amino acids 208-440) and rabbit α-Yki (1:50, produced by immunizing rabbits with the peptide of Yki amino acids 180-418) were used. Fluorescent stains were captured on a Leica LAS SP5 confocal microscope. ware. The efficiency of FRET was calculated according to a previous paper [47] .
